Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N-Acetylglucosamine Selectively Attenuates Neuroinflammation in a Mouse Model of Mitochondrial Dysfunction.

Acta physiologica (Oxford, England)·2026
Same author

Consensus document on frailty: conceptualization, detection, multidisciplinary management and future roadmap.

The journal of nutrition, health & aging·2026
Same author

MelAnalyze: fact-checking melatonin claims using large language models and natural language inference.

BMC medical informatics and decision making·2025
Same author

Melatonin Overcomes Cancer Multidrug Resistance by Downregulating ABCB1 Expression and Modulating Mitochondrial Function.

Journal of pineal research·2025
Same author

Redox Status in Patients Suffering from Multiple Chemical Sensitivity (MCS): A Pilot Study.

Journal of clinical medicine·2025
Same author

Melatonin Secretion and Impacts of Training and Match Schedules on Sleep Quality, Recovery, and Circadian Rhythms in Young Professional Football Players.

Biomolecules·2025

Related Experiment Video

Updated: Jun 22, 2026

A Protocol for Transcranial Photobiomodulation Therapy in Mice
13:07

A Protocol for Transcranial Photobiomodulation Therapy in Mice

Published on: November 18, 2018

Long-term melatonin administration protects brain mitochondria from aging.

Miguel Carretero1, Germaine Escames1,2, Luis C López1,2

  • 1Centro de Investigación Biomédica, Parque Tecnológico de Ciencias de la Salud, Universidad de Granada and RETICEF, Granada, Spain.

Journal of Pineal Research
|July 4, 2009
PubMed
Summary

Chronic melatonin administration prevents brain mitochondrial dysfunction during aging. This study shows melatonin maintains mitochondrial function and ATP production, crucial for brain health in aging mice.

More Related Videos

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
06:42

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

Published on: April 16, 2018

Related Experiment Videos

Last Updated: Jun 22, 2026

A Protocol for Transcranial Photobiomodulation Therapy in Mice
13:07

A Protocol for Transcranial Photobiomodulation Therapy in Mice

Published on: November 18, 2018

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
06:42

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

Published on: April 16, 2018

Area of Science:

  • Neuroscience
  • Gerontology
  • Mitochondrial Biology

Background:

  • Aging is associated with progressive brain mitochondrial dysfunction.
  • Mitochondrial impairment involves oxidative stress, reduced electron transport chain activity, and diminished ATP production.
  • Senescent prone (SAMP8) mice model age-related cognitive decline and mitochondrial deficits.

Purpose of the Study:

  • To investigate the efficacy of chronic melatonin administration in preventing age-related brain mitochondrial impairment.
  • To assess the impact of melatonin on oxidative stress markers and mitochondrial bioenergetics in aging mice.
  • To determine if melatonin can maintain brain mitochondrial function throughout the aging process.

Main Methods:

  • Brain mitochondria were isolated from male and female SAMP8 mice at 5 and 10 months of age.
  • Mitochondrial oxidative stress was evaluated by measuring lipid peroxidation, nitrite levels, glutathione redox state, and antioxidant enzyme activities.
  • Electron transport chain complex activities and ATP content were measured to assess mitochondrial bioenergetic function.

Main Results:

  • Significant age-dependent mitochondrial dysfunction was observed, characterized by increased oxidative/nitrosative stress and reduced ATP production.
  • Chronic melatonin administration from 1 to 10 months of age completely prevented mitochondrial impairment.
  • Melatonin treatment maintained or enhanced ATP production and electron transport chain efficiency; females showed slightly higher sensitivity.

Conclusions:

  • Chronic melatonin administration is a potent therapeutic strategy to preserve brain mitochondrial function during aging.
  • Melatonin effectively counteracts age-related mitochondrial oxidative stress and bioenergetic decline.
  • These findings highlight melatonin's potential role in mitigating the pathophysiology of brain aging.